3 lotion companies fail to prove ‘skin whitening’ claims, fined
NEW DELHI: Advertisements on e-commerce platforms that claim certain body lotion can whiten your skin in just minutes always sounded fictitious. What you doubted has turned out to be true.…
Alembic Pharma receives USFDA final approval for Pantoprazole Sodium Injection
Alembic Pharmaceuticals (Alembic) announced that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Pantoprazole Sodium. The approved…
Maharashtra starts inspection of blood banks to check violation
The Maharashtra state health department has directed district blood transfusion officers to inspect blood banks across the state and submit report within a month, said officials on Saturday. The State…
State set to issue instructions to med shops to put up QR codes
Kolkata: In the wake of a series of fake medicines being recovered from various parts of the state, the state Health department is set to issue instructions to medicine shops…
Dabur To Withdraw ‘Anti-bacterial’ Claims from Toothpaste Labels
Dabur India Ltd has told the Bombay High Court that it will withdraw terms like “anti-inflammatory,” “anti-bacterial,” and “analgesic” from the labels of its two toothpaste products, Dabur Meswak Toothpaste…
Cancer, diabetes drugs under government price control to get costlier
Government-controlled medicines, including that of cancer, diabetes, heart-related concerns and other antibiotics, will soon get costlier, government sources told India Today TV’s sister publication, Business Today. These medicines are expected…
Traws Pharma announces CEO retirement and interim successor
NEWTOWN, Pa. – Traws Pharma, Inc. (NASDAQ: TRAW), a biopharmaceutical company focusing on antiviral therapies, has announced the retirement of its CEO, Werner Cautreels, PhD, effective at the close of…
Mankind Pharma faces Rs 183 crore tax demand, plans to appeal
Mankind Pharma has received tax demand orders from the Income Tax Department for Assessment Years (AY) 2014-15 to 2017-18, amounting to ₹183.11 crore, including interest. The demand arises from the…
Indian Pharma Poised To Gain As US Tariffs Impact Global Rivals: JP Morgan Report
Mumbai: Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan report. Essentially, Indian pharmaceutical companies have the potential…
















